These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 33493139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, Schweizer L, Korshunov A, Jones DT, Hovestadt V, Mittelbronn M, Schittenhelm J, Herold-Mende C, Unterberg A, Platten M, Weller M, Wick W, Pfister SM, von Deimling A.
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Unveiling hierarchy and spatial distribution of O6-methylguanine-DNA methyltransferase promoter methylation in World Health Organization grade 2-3 gliomas.
    Li M, Liu J, Weng J, Dong G, Chen X, Cui Y, Ren X, Shen S, Jiang H, Zhang X, Zhao X, Li M, Wang X, Ren H, Li Q, Zhang Y, Cheng Q, Yu Y, Lin S.
    Cancer Sci; 2024 Oct; 115(10):3403-3414. PubMed ID: 39101880
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.
    Liang T, Zhou X, Li P, You G, Wang F, Wang P, Feng E.
    Aging (Albany NY); 2020 Nov 21; 12(24):24995-25004. PubMed ID: 33229627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX, Wang JX, Feng M, Sun CM, Sun T, Chen GL, Du ZW.
    J Mol Neurosci; 2012 Jul 21; 47(3):442-7. PubMed ID: 22113362
    [Abstract] [Full Text] [Related]

  • 13. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
    Kim HS, Kwon MJ, Song JH, Kim ES, Kim HY, Min KW.
    Pathol Res Pract; 2018 Jun 21; 214(6):881-888. PubMed ID: 29650441
    [Abstract] [Full Text] [Related]

  • 14. Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study.
    Ang SYL, Lee L, See AAQ, Ang TY, Ang BT, King NKK.
    BMC Cancer; 2020 Jan 31; 20(1):79. PubMed ID: 32005184
    [Abstract] [Full Text] [Related]

  • 15. BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.
    Cho HR, Jeon H, Park CK, Park SH, Kang KM, Choi SH.
    Sci Rep; 2017 Dec 18; 7(1):17740. PubMed ID: 29255149
    [Abstract] [Full Text] [Related]

  • 16. Clinical Relevance of Prognostic and Predictive Molecular Markers in Gliomas.
    Siegal T.
    Adv Tech Stand Neurosurg; 2016 Dec 18; (43):91-108. PubMed ID: 26508407
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment.
    July J, Patricia D, Gunawan PY, Setiajaya H, Ginting TE, Putra TP, Wuisan Z, Budhiarko D, Masykura N, Prayogi G, Utomo AR, Tandean S, Loe ML.
    Pan Afr Med J; 2020 Dec 18; 36():309. PubMed ID: 33282092
    [Abstract] [Full Text] [Related]

  • 18. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
    Geevar T, Pai R, Chacko G, Malepathi K, Patel B, John J, Chacko AG, Balakrishnan R, John S.
    Neurol India; 2018 Dec 18; 66(6):1726-1731. PubMed ID: 30504574
    [Abstract] [Full Text] [Related]

  • 19. Molecular biology of high-grade gliomas: what should the clinician know?
    Hofer S, Rushing E, Preusser M, Marosi C.
    Chin J Cancer; 2014 Jan 18; 33(1):4-7. PubMed ID: 24325789
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.
    Kong LW, Chen J, Zhao H, Yao K, Fang SY, Wang Z, Wang YY, Li SW.
    Sci Rep; 2019 Nov 19; 9(1):17080. PubMed ID: 31745161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.